Asia-Pacific consensus on long-term and sequential therapy for osteoporosis.
Tai, T-W
Chen, H-Y
Shih, C-A
Huang, C-F
McCloskey, E
Lee, J-K
Yeap, SS
Cheung, C-L
Charatcharoenwitthaya, N
Jaisamrarn, U
Kuptniratsaikul, V
Yang, R-S
Lin, S-Y
Taguchi, A
Mori, S
Li-Yu, J
Ang, SB
Chan, D-C
Chan, WS
Ng, H
Chen, J-F
Tu, S-T
Chuang, H-H
Chang, Y-F
Chen, F-P
Tsai, K-S
Ebeling, PR
Marin, F
Nistal Rodríguez, FJ
Shi, H
Hwang, KR
Kim, K-K
Chung, Y-S
Reid, IR
Chandran, M
Ferrari, S
Lewiecki, EM
Hew, FL
Ho-Pham, LT
Nguyen, TV
Nguyen, VH
Lekamwasam, S
Pandey, D
Bhadada, S
Chen, C-H
Hwang, J-S
Wu, C-H
- Publisher:
- ELSEVIER
- Publication Type:
- Journal Article
- Citation:
- Osteoporos Sarcopenia, 2024, 10, (1), pp. 3-10
- Issue Date:
- 2024-03
Open Access
Copyright Clearance Process
- Recently Added
- In Progress
- Open Access
This item is open access.
Full metadata record
Field | Value | Language |
---|---|---|
dc.contributor.author | Tai, T-W | |
dc.contributor.author | Chen, H-Y | |
dc.contributor.author | Shih, C-A | |
dc.contributor.author | Huang, C-F | |
dc.contributor.author | McCloskey, E | |
dc.contributor.author | Lee, J-K | |
dc.contributor.author | Yeap, SS | |
dc.contributor.author | Cheung, C-L | |
dc.contributor.author | Charatcharoenwitthaya, N | |
dc.contributor.author | Jaisamrarn, U | |
dc.contributor.author | Kuptniratsaikul, V | |
dc.contributor.author | Yang, R-S | |
dc.contributor.author | Lin, S-Y | |
dc.contributor.author | Taguchi, A | |
dc.contributor.author | Mori, S | |
dc.contributor.author | Li-Yu, J | |
dc.contributor.author | Ang, SB | |
dc.contributor.author | Chan, D-C | |
dc.contributor.author | Chan, WS | |
dc.contributor.author | Ng, H | |
dc.contributor.author | Chen, J-F | |
dc.contributor.author | Tu, S-T | |
dc.contributor.author | Chuang, H-H | |
dc.contributor.author | Chang, Y-F | |
dc.contributor.author | Chen, F-P | |
dc.contributor.author | Tsai, K-S | |
dc.contributor.author | Ebeling, PR | |
dc.contributor.author | Marin, F | |
dc.contributor.author | Nistal Rodríguez, FJ | |
dc.contributor.author | Shi, H | |
dc.contributor.author | Hwang, KR | |
dc.contributor.author | Kim, K-K | |
dc.contributor.author | Chung, Y-S | |
dc.contributor.author | Reid, IR | |
dc.contributor.author | Chandran, M | |
dc.contributor.author | Ferrari, S | |
dc.contributor.author | Lewiecki, EM | |
dc.contributor.author | Hew, FL | |
dc.contributor.author | Ho-Pham, LT | |
dc.contributor.author | Nguyen, TV | |
dc.contributor.author | Nguyen, VH | |
dc.contributor.author | Lekamwasam, S | |
dc.contributor.author | Pandey, D | |
dc.contributor.author | Bhadada, S | |
dc.contributor.author | Chen, C-H | |
dc.contributor.author | Hwang, J-S | |
dc.contributor.author | Wu, C-H | |
dc.date.accessioned | 2024-08-01T03:59:35Z | |
dc.date.available | 2024-02-17 | |
dc.date.available | 2024-08-01T03:59:35Z | |
dc.date.issued | 2024-03 | |
dc.identifier.citation | Osteoporos Sarcopenia, 2024, 10, (1), pp. 3-10 | |
dc.identifier.issn | 2405-5255 | |
dc.identifier.issn | 2405-5263 | |
dc.identifier.uri | http://hdl.handle.net/10453/179915 | |
dc.description.abstract | OBJECTIVES: This study aimed to present the Asia-Pacific consensus on long-term and sequential therapy for osteoporosis, offering evidence-based recommendations for the effective management of this chronic condition. The primary focus is on achieving optimal fracture prevention through a comprehensive, individualized approach. METHODS: A panel of experts convened to develop consensus statements by synthesizing the current literature and leveraging clinical expertise. The review encompassed long-term anti-osteoporosis medication goals, first-line treatments for individuals at very high fracture risk, and the strategic integration of anabolic and antiresorptive agents in sequential therapy approaches. RESULTS: The panelists reached a consensus on 12 statements. Key recommendations included advocating for anabolic agents as the first-line treatment for individuals at very high fracture risk and transitioning to antiresorptive agents following the completion of anabolic therapy. Anabolic therapy remains an option for individuals experiencing new fractures or persistent high fracture risk despite antiresorptive treatment. In cases of inadequate response, the consensus recommended considering a switch to more potent medications. The consensus also addressed the management of medication-related complications, proposing alternatives instead of discontinuation of treatment. CONCLUSIONS: This consensus provides a comprehensive, cost-effective strategy for fracture prevention with an emphasis on shared decision-making and the incorporation of country-specific case management systems, such as fracture liaison services. It serves as a valuable guide for healthcare professionals in the Asia-Pacific region, contributing to the ongoing evolution of osteoporosis management. | |
dc.format | Print-Electronic | |
dc.language | eng | |
dc.publisher | ELSEVIER | |
dc.relation.ispartof | Osteoporos Sarcopenia | |
dc.relation.isbasedon | 10.1016/j.afos.2024.02.001 | |
dc.rights | info:eu-repo/semantics/openAccess | |
dc.subject.classification | 3202 Clinical sciences | |
dc.title | Asia-Pacific consensus on long-term and sequential therapy for osteoporosis. | |
dc.type | Journal Article | |
utslib.citation.volume | 10 | |
utslib.location.activity | Netherlands | |
pubs.organisational-group | University of Technology Sydney | |
pubs.organisational-group | University of Technology Sydney/Faculty of Engineering and Information Technology | |
pubs.organisational-group | University of Technology Sydney/Strength - CHT - Health Technologies | |
pubs.organisational-group | University of Technology Sydney/Faculty of Engineering and Information Technology/School of Biomedical Engineering | |
pubs.organisational-group | University of Technology Sydney/All Manual Groups | |
pubs.organisational-group | University of Technology Sydney/All Manual Groups/UTS Ageing Research Collaborative (UARC) | |
pubs.organisational-group | University of Technology Sydney/All Manual Groups/Centre for Health Technologies (CHT) | |
utslib.copyright.status | open_access | * |
dc.rights.license | This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0). To view a copy of this license, visit https://creativecommons.org/licenses/by-nc-nd/4.0/ | |
dc.date.updated | 2024-08-01T03:59:27Z | |
pubs.issue | 1 | |
pubs.publication-status | Published | |
pubs.volume | 10 | |
utslib.citation.issue | 1 |
Abstract:
OBJECTIVES: This study aimed to present the Asia-Pacific consensus on long-term and sequential therapy for osteoporosis, offering evidence-based recommendations for the effective management of this chronic condition. The primary focus is on achieving optimal fracture prevention through a comprehensive, individualized approach. METHODS: A panel of experts convened to develop consensus statements by synthesizing the current literature and leveraging clinical expertise. The review encompassed long-term anti-osteoporosis medication goals, first-line treatments for individuals at very high fracture risk, and the strategic integration of anabolic and antiresorptive agents in sequential therapy approaches. RESULTS: The panelists reached a consensus on 12 statements. Key recommendations included advocating for anabolic agents as the first-line treatment for individuals at very high fracture risk and transitioning to antiresorptive agents following the completion of anabolic therapy. Anabolic therapy remains an option for individuals experiencing new fractures or persistent high fracture risk despite antiresorptive treatment. In cases of inadequate response, the consensus recommended considering a switch to more potent medications. The consensus also addressed the management of medication-related complications, proposing alternatives instead of discontinuation of treatment. CONCLUSIONS: This consensus provides a comprehensive, cost-effective strategy for fracture prevention with an emphasis on shared decision-making and the incorporation of country-specific case management systems, such as fracture liaison services. It serves as a valuable guide for healthcare professionals in the Asia-Pacific region, contributing to the ongoing evolution of osteoporosis management.
Please use this identifier to cite or link to this item:
Download statistics for the last 12 months
Not enough data to produce graph